Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ZELDOX DIN 02298597

Status: Marketed
Holder: BGP PHARMA ULC
Molecule: ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE)
Available to quote

Health Canada record

Active ingredient(s)ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCN05AE04 ZIPRASIDONE
Original market date04-Jan-2008
Current status date15-Sep-2023
SourceHealth Canada DPD

Establishment licence of the holder

BGP Pharma ULC — licence 102234, currently licensed, last inspection rating C (2026-02-24).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE)

DINProductCompanyFormStrengthStatus
02449579AURO-ZIPRASIDONEAURO PHARMA INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MGMarketed
02449560AURO-ZIPRASIDONEAURO PHARMA INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MGMarketed
02449552AURO-ZIPRASIDONEAURO PHARMA INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MGMarketed
02449544AURO-ZIPRASIDONEAURO PHARMA INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MGMarketed
02298627ZELDOXBGP PHARMA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MGMarketed
02298600ZELDOXBGP PHARMA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MGMarketed
02298619ZELDOXBGP PHARMA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MGMarketed
02441373GD-ZIPRASIDONEGENMED A DIVISION OF PFIZER CANADA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MGCancelled Pre Market
02441357GD-ZIPRASIDONEGENMED A DIVISION OF PFIZER CANADA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MGCancelled Pre Market
02441365GD-ZIPRASIDONEGENMED A DIVISION OF PFIZER CANADA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MGCancelled Pre Market
02441381GD-ZIPRASIDONEGENMED A DIVISION OF PFIZER CANADA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MGCancelled Pre Market
02429403MYLAN-ZIPRASIDONEMYLAN PHARMACEUTICALS ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MGCancelled Pre Market
02429381MYLAN-ZIPRASIDONEMYLAN PHARMACEUTICALS ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MGCancelled Pre Market
02429373MYLAN-ZIPRASIDONEMYLAN PHARMACEUTICALS ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MGCancelled Pre Market
02429365MYLAN-ZIPRASIDONEMYLAN PHARMACEUTICALS ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MGCancelled Pre Market
02478803PMS-ZIPRASIDONEPHARMASCIENCE INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MGCancelled Pre Market
02478811PMS-ZIPRASIDONEPHARMASCIENCE INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MGCancelled Pre Market
02478838PMS-ZIPRASIDONEPHARMASCIENCE INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MGCancelled Pre Market
02478846PMS-ZIPRASIDONEPHARMASCIENCE INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
316472023-09-15New Drug Submission (NDS)Administrative: Change in Product Ownership
235712020-05-06New Drug Submission (NDS)CHANGE OF PRODUCT OWNERSHIP
89952007-08-27New Drug Submission (NDS)
Request a quote for ZELDOX

How to read a Canadian DIN record